Outpatient parenteral antibiotic therapy for bone and joint infections: An Italian multicenter study

Journal of Chemotherapy

Volumn 19, Issue 4, 2007, Pages 417-422

  Esposito, Silvano ^a,o   Leone, S ^a   Noviello, S ^a   Ianniello, F ^a   Fiore, M ^a   Russo, M ^a   Foti, G ^b   Carpentieri, M S ^b   Cellesi, C ^c   Zanelli, G ^c   Cellini, A ^d   Girmenia, C ^e   De Lalla, F ^f   Maiello, A ^g   Maio, P ^h   Marranconi, F ⁱ   Sabbatani, S ^j   Pantaleoni, M ^k   Ghinelli, F ^k   Soranzo, M L ^g   Vigano P ^l   Re, T ^l   Viale, P ^m   Scudeller, L ^m   Scaglione, F ⁿ   Vullo, V ^e   more..

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

^d SAN SALVATORE HOSPITAL   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f Ospedale Civile Di Vicenza   (Italy)

^g AMEDEO DI SAVOIA HOSPITAL   (Italy)

^h S G MOSCATI HOSPITAL   (Italy)

ⁱ Ospedale di Schio   (Italy)

^j UNIVERSITY OF BOLOGNA   (Italy)

^k AO Sant'Anna   (Italy)

^l Ospedale Civile di Legnano   (Italy)

^m UNIVERSITY HOSPITAL OF UDINE   (Italy)

ⁿ UNIVERSITY OF MILAN   (Italy)

^o Clinica Malattie Infettive   (Italy)

more..

Author keywords

Bone infections; Ceftriaxone; Ciprofloxacin; Joint infections; Levofloxacin; OPAT; Outpatient parenteral antibiotic therapy; Teicoplanin

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; GENTAMICIN; LEVOFLOXACIN; NETILMICIN; OXACILLIN; PEFLOXACIN; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

ADULT; AGED; ANAPHYLAXIS; ARTICLE; BACTERIAL ARTHRITIS; BONE INFECTION; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; DIARRHEA; FEMALE; FEVER; FOLLOW UP; HUMAN; INFECTIOUS ARTHRITIS; ITALY; JOINT PROSTHESIS; KIDNEY FAILURE; LEUKOPENIA; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; NAUSEA; OSTEOARTHROPATHY; OSTEOMYELITIS; OUTCOME ASSESSMENT; OUTPATIENT; PATIENT COMPLIANCE; PATIENT SATISFACTION; PROSTHESIS INFECTION; PRURITUS; RASH; RECURRENT DISEASE; SPONDYLITIS; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; URTICARIA; VOMITING;

EID: 34547795298     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2007.19.4.417     Document Type: Article

References (16)

1. Antoniskis A, Anderson BC, Van Volkinburg EJ, Jackson JM, Gilbert DN. Feasibility of outpatient self-administration of parenteral antibiotics. West J Med 1978; 128: 203-206.
2. Tice AD, Rehm SJ, Dalovisio JR, Bradley JS, Martinelli LP, Graham DR, et al. Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines. Clin Infect Dis 2004; 38: 1651-1672.
3. Esposito S, Noviello S, Leone S, Tice A, Seibold G, Nathwani D, et al. International OPAT Registry. Outpatient parenteral antibiotic therapy (OPAT) in different countries: a comparison. Int J Antimicrob Agents 2004; 24: 473-478.
4. Esposito S. Outpatient parenteral treatment of bacterial infections: the Italian model as an international trend? J Antimicrob Chemother 2000; 45: 724-727.
5. Esposito S. Outpatient parenteral antibiotic treatment: the Italian model. Infez Med 2000; 9: 7-12.
6. Esposito S, Ianniello F, Noviello S, Leone S, Ascione T, Tice A, et al. Outpatient Parenteral Antibiotic Therapy (OPAT): the Italian registry. Infez Med 2002; 10: 169-175.
7. Tice AD. The use of outpatient parenteral antimicrobial therapy in the management of osteomyelitis: data from the Outpatient Parenteral Antimicrobial Therapy Outcomes Registries. Chemotherapy 2001; 47: 5-16. 8 Vinen J. Intravenous antibiotic treatment outside the hospital: safety and healthy economic aspects. Rev Contemp Pharmacother 1995; 6: 435-445.
8. Upton A, Ellis-Pegler RB, Woodhouse A. Outpatient Parenteral Antimicrobial Therapy (OPAT): a review of experience at Auckland Hospital. NZ Med J 2004; 20: 117: 1020.
9. Maraqa NF, Gomez MM, Rathore MH. Outpatient parenteral antimicrobial therapy in osteoarticular infections in children. J Ped Orthopaed 2002;22: 506-510.
10. Bernard L, El-haj J, Pron B, Lotthé A, Gleizes V, Signoret F, et al. Outpatient parenteral antimicrobial therapy (OPAT) for the treatment of osteomyelitis: evaluation of efficacy, tolerance and cost. J Clin Pharm Therapeut 2001; 26: 445-451.
11. Dacquet V. Treatment of bone e joint infection with teicoplanin: a retrospective analysis of 50 cases. Int J Antimicrob Agents 1996; 7: 49-51.
12. LeFrock J, Ristuccia A. Teicoplanin in the treatment of bone and joint infections: an open study. J Infect Chemother 1999; 5: 32-39.
13. Guglielmo BJ, Luber AD, Paletta D, Jacobs RA. Ceftriaxone therapy for staphylococcal osteomyelitis: a review. Clin Infect Dis 2000; 30: 205-207.
14. Tice AD, Hoaglund PA, Shoultz DA. Risk factors and treatment outcomes in osteomyelitis. J Antimicrob Agents 2003; 51: 1261-1268.
15. Williams DN, Bosch D, Boots J, Schneider J. Safety, efficacy, and cost savings in an out-patient intravenous antibiotic program. Clin Therapeut 1993; 15: 169-179.
16. de Lalla F. Outpatient therapy for febrile neutropenia: clinical and economic implications. Pharmacoeconomics 2003; 21: 397-413.